Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: Esketamine vs ECT for Acute Suicidality [NA]

View source ↗

Summary

A completed clinical trial comparing esketamine with electroconvulsive therapy for acute suicidality in mood disorders has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)

Snippet

Sponsor: Capital Medical University | Conditions: Mood Disorders, Suicidal Ideation | NA | Status: COMPLETED